22Mar
HHS Declares Liability Immunity for Certain COVID-19 “Countermeasures”; Response Act Expands Protections for Mask Makers
Earlier this week, we discussed current trends and future implications of COVID-19 on businesses operating in the products arena, noting the most direct impact so far on the pharmaceutical and medical device spaces. Recognizing the potential...
By:
Butler Snow LLP
Related
In his first year in office, California Governor Gavin Newsom signed several laws impacting Californ...
Read More >
Downturns can be challenging for any company, but the current COVID-19 pandemic shows once more (as ...
Read More >
Since 1991, California employers with 10 employees or more have been required to develop written wor...
Read More >
The Eighth Circuit recently concluded that there was no contractual basis to conclude that a pharmac...
Read More >
Why This Matters - Earlier this month, the U.S. Supreme Court unanimously ruled in Fort Bend County...
Read More >
The Diversity Visa (DV) Lottery Registration for 2021 opens Wednesday, October 2, 2019. Entries must...
Read More >